Terms: = Leukemia AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Clinical Outcome
24 results:
1. Phenotype, Function, and clinical Significance of CD26+ and CD161+Tregs in Splenic Marginal Zone Lymphoma.
Tang X; Yang ZZ; Kim HJ; Anagnostou T; Yu Y; Wu X; Chen J; Krull JE; Wenzl K; Mondello P; Bhardwaj V; Wang J; Novak AJ; Ansell SM
Clin Cancer Res; 2022 Oct; 28(19):4322-4335. PubMed ID: 35686915
[TBL] [Abstract] [Full Text] [Related]
2. Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and outcome of Immunotherapy in Acute Myeloid leukemia.
Hussein BA; Hallner A; Wennström L; Brune M; Martner A; Hellstrand K; Bernson E; Thorén FB
Front Immunol; 2021; 12():796072. PubMed ID: 34956230
[TBL] [Abstract] [Full Text] [Related]
3. Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML.
Aurelius J; Möllgård L; Kiffin R; Ewald Sander F; Nilsson S; Thorén FB; Hellstrand K; Martner A
Leuk Lymphoma; 2019 Nov; 60(11):2771-2778. PubMed ID: 30991860
[TBL] [Abstract] [Full Text] [Related]
4. The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.
Hallner A; Bernson E; Hussein BA; Ewald Sander F; Brune M; Aurelius J; Martner A; Hellstrand K; Thorén FB
Blood; 2019 Mar; 133(13):1479-1488. PubMed ID: 30647027
[TBL] [Abstract] [Full Text] [Related]
5. Histamine targets myeloid-derived suppressor cells and improves the anti-tumor efficacy of PD-1/PD-L1 checkpoint blockade.
Grauers Wiktorin H; Nilsson MS; Kiffin R; Sander FE; Lenox B; Rydström A; Hellstrand K; Martner A
Cancer Immunol Immunother; 2019 Feb; 68(2):163-174. PubMed ID: 30315349
[TBL] [Abstract] [Full Text] [Related]
6. il-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.
Nakase K; Kita K; Katayama N
Med Hypotheses; 2018 Jun; 115():5-7. PubMed ID: 29685196
[TBL] [Abstract] [Full Text] [Related]
7. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.
Sander FE; Nilsson M; Rydström A; Aurelius J; Riise RE; Movitz C; Bernson E; Kiffin R; Ståhlberg A; Brune M; Foà R; Hellstrand K; Thorén FB; Martner A
Cancer Immunol Immunother; 2017 Nov; 66(11):1473-1484. PubMed ID: 28721449
[TBL] [Abstract] [Full Text] [Related]
8. Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.
Bernson E; Hallner A; Sander FE; Wilsson O; Werlenius O; Rydström A; Kiffin R; Brune M; Foà R; Aurelius J; Martner A; Hellstrand K; Thorén FB
Leukemia; 2017 Dec; 31(12):2552-2559. PubMed ID: 28529313
[TBL] [Abstract] [Full Text] [Related]
9. Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.
Rydström A; Hallner A; Aurelius J; Sander FE; Bernson E; Kiffin R; Thoren FB; Hellstrand K; Martner A
J Leukoc Biol; 2017 Aug; 102(2):467-474. PubMed ID: 28235771
[TBL] [Abstract] [Full Text] [Related]
10. Killer immunoglobulin-like receptor (KIR) and KIR-ligand genotype do not correlate with clinical outcome of renal cell carcinoma patients receiving high-dose il2.
Wang W; Erbe AK; Gallenberger M; Kim K; Carmichael L; Hess D; Mendonca EA; Song Y; Hank JA; Cheng SC; Signoretti S; Atkins M; Carlson A; Weiss JM; Mier J; Panka D; McDermott DF; Sondel PM
Cancer Immunol Immunother; 2016 Dec; 65(12):1523-1532. PubMed ID: 27695964
[TBL] [Abstract] [Full Text] [Related]
11. Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients.
Govindaraj C; Madondo M; Kong YY; Tan P; Wei A; Plebanski M
Am J Hematol; 2014 Aug; 89(8):795-802. PubMed ID: 24757092
[TBL] [Abstract] [Full Text] [Related]
12. Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients.
Monserrat J; Sánchez MÁ; de Paz R; Díaz D; Mur S; Reyes E; Prieto A; de la Hera A; Martínez-A C; Alvarez-Mon M
Cytometry B Clin Cytom; 2014 Jan; 86(1):32-43. PubMed ID: 24166938
[TBL] [Abstract] [Full Text] [Related]
13. Efficacy and safety of adoptive immunotherapy using anti-CD19 chimeric antigen receptor transduced T-cells: a systematic review of phase I clinical trials.
Xu XJ; Zhao HZ; Tang YM
Leuk Lymphoma; 2013 Feb; 54(2):255-60. PubMed ID: 22897728
[TBL] [Abstract] [Full Text] [Related]
14. A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT.
Martín-Antonio B; Álvarez-Laderas I; Cardesa R; Márquez-Malaver F; Baez A; Carmona M; Falantes J; Suarez-Lledo M; Fernández-Avilés F; Martínez C; Rovira M; Espigado I; Urbano-Ispizua Á
Bone Marrow Transplant; 2012 Sep; 47(9):1206-11. PubMed ID: 22231458
[TBL] [Abstract] [Full Text] [Related]
15. In vivo expression of human T-lymphotropic virus type 1 basic leucine-zipper protein generates specific CD8+ and CD4+ T-lymphocyte responses that correlate with clinical outcome.
Hilburn S; Rowan A; Demontis MA; MacNamara A; Asquith B; Bangham CR; Taylor GP
J Infect Dis; 2011 Feb; 203(4):529-36. PubMed ID: 21208912
[TBL] [Abstract] [Full Text] [Related]
16. Elevated frequencies of CD4⁺ CD25⁺ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract] [Full Text] [Related]
17. CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells.
Deaglio S; Vaisitti T; Zucchetto A; Gattei V; Malavasi F
Semin Cancer Biol; 2010 Dec; 20(6):416-23. PubMed ID: 20817095
[TBL] [Abstract] [Full Text] [Related]
18. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract] [Full Text] [Related]
19. Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.
Mayr C; Speicher MR; Kofler DM; Buhmann R; Strehl J; Busch R; Hallek M; Wendtner CM
Blood; 2006 Jan; 107(2):742-51. PubMed ID: 16179374
[TBL] [Abstract] [Full Text] [Related]
20. Elevated levels of soluble CD44 are associated with advanced disease and in vitro proliferation of neoplastic lymphocytes in B-cell chronic lymphocytic leukaemia.
Eisterer W; Bechter O; Söderberg O; Nilsson K; Terol M; Greil R; Thaler J; Herold M; Finke L; Günthert U; Montserrat E; Stauder R
Leuk Res; 2004 Oct; 28(10):1043-51. PubMed ID: 15289016
[TBL] [Abstract] [Full Text] [Related]
[Next]
